Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Therapy with topical corticosteroids.

W Sterry1

  • 1Department of Dermatology, University of Ulm, Federal Republic of Germany.

Archives of Dermatological Research
|January 1, 1992
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Tinea capitis in Germany. A survey in 1998.

Mycoses·2017
Same author

Dose-escalation study evaluating pegylated interferon alpha-2a in patients with cutaneous T-cell lymphoma.

Journal of the European Academy of Dermatology and Venereology : JEADV·2017
Same author

Lipocalin-2 is expressed by activated granulocytes and keratinocytes in affected skin and reflects disease activity in acne inversa/hidradenitis suppurativa.

The British journal of dermatology·2017
Same author

The 2016 International League of Dermatological Societies' revised glossary for the description of cutaneous lesions.

The British journal of dermatology·2016
Same author

Interleukin-10 receptor-1 expression in monocyte-derived antigen-presenting cell populations: dendritic cells partially escape from IL-10's inhibitory mechanisms.

Genes and immunity·2014
Same author

Pattern of response in patients with moderate-to-severe psoriasis treated with etanercept.

The British journal of dermatology·2014
Same journal

Transgender Individuals' Perspectives on Teledermatology-Based Acne Research.

Archives of dermatological research·2026
Same journal

Nicotinamide for secondary keratinocyte carcinoma prevention in solid organ transplant recipients.

Archives of dermatological research·2025
Same journal

Off-label use of biologics and janus kinase (JAK) inhibitors for scarring alopecias: a narrative review.

Archives of dermatological research·2025
Same journal

Wells syndrome: emerging triggers and treatments- an updated systematic review.

Archives of dermatological research·2025
Same journal

Comparative study between intralesional acyclovir versus intralesional 5-flurouracil in treatment of recalcitrant warts.

Archives of dermatological research·2025
Same journal

Assessment of efficacy of carboxytherapy in reducing thickness of abdominal subcutaneous fat through clinical and ultrasonographical studies: a randomized 2-split clinical trial.

Archives of dermatological research·2025
See all related articles

Topical corticosteroid therapy is safe and effective for skin conditions when specific guidelines are followed. Addressing patient fear through education ensures treatment compliance and optimal outcomes.

Area of Science:

  • Dermatology
  • Pharmacology

Background:

  • Topical corticosteroid therapy has advanced significantly due to better understanding of mechanisms and new drug development.
  • Public fear of corticosteroids has paradoxically increased despite therapeutic improvements.

Purpose of the Study:

  • To outline essential guidelines for the safe and successful use of topical corticosteroids in treating skin disorders.
  • To address patient concerns and improve compliance with corticosteroid therapy.

Main Methods:

  • Classification of topical corticosteroids into four potency groups (weak, medium, strong, very strong).
  • Consideration of disease diagnosis, required potency, treatment duration, and appropriate vehicle selection.
  • Evaluation of systemic side effects for large-area treatments, recommending rapidly absorbed compounds.

Related Experiment Videos

Main Results:

  • Adherence to specific guidelines ensures successful and safe topical corticosteroid treatment.
  • Patient-tailored treatment plans utilizing different potencies are effective.
  • Careful patient education is crucial for managing corticophobia and ensuring compliance.

Conclusions:

  • Topical corticosteroid therapy can be highly effective, user-friendly, and safe when administered correctly.
  • Key factors include accurate diagnosis, appropriate potency selection, defined treatment schedules, and suitable vehicles.
  • Addressing patient education and fear is vital for maximizing therapeutic benefits and safety.